References
- Lewandowska-Pietruszka Z, Figlerowicz M, Mazur-Melewska K. The History of the Intestinal Microbiota and the Gut-Brain Axis. Pathogens. 2022;11(12):1540. doi:10.3390/pathogens11121540
- Nanthakumaran S, Sridharan S, Somagutta MR, et al. The Gut-Brain Axis and Its Role in Depression. Cureus. 2020;12(9). doi:10.7759/cureus.10280
- La microbiota intestinal y surelación con las enfermedadesmentales a través del eje microbiotaintestino-cerebro. Accessed July 11, 2023. http://riberdis.cedid.es/handle/11181/5361
- Liu Y, Sanderson D, Mian MF, McVey Neufeld KA, Forsythe P. Loss of vagal integrity disrupts immune components of the microbiota-gut-brain axis and inhibits the effect of Lactobacillus rhamnosus on behavior and the corticosterone stress response. Neuropharmacology. 2021;195:108682. doi:10.1016/j.neuropharm.2021.108682
- Gorecki AM, Dunlop SA, Rodger J, Anderton RS. The gut-brain axis and gut inflammation in Parkinson's disease: stopping neurodegeneration at the toll gate. Expert Opinion on Therapeutic Targets. 2020;24(7):601-604. doi:10.1080/14728222.2020.1763956
- Mayer EA, Nance K, Chen S. The Gut–Brain Axis. Annual Review of Medicine. 2022;73(1):439-453. doi:10.1146/annurev-med-042320-014032
- Xie Y, Zhou G, Wang C, Xu X, Li C. Specific Microbiota Dynamically Regulate the Bidirectional Gut–Brain Axis Communications in Mice Fed Meat Protein Diets. J Agric Food Chem. 2019;67(3):1003-1017. doi:10.1021/acs.jafc.8b05654
- Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Reddy DN. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787-8803. doi:10.3748/wjg.v21.i29.8787
- Kennedy EA, King KY, Baldridge MT. Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria. Frontiers in Physiology. 2018;9. Accessed July 11, 2023. https://www.frontiersin.org/articles/10.3389/fphys.2018.01534
- Bajaj JS, Barbara G, DuPont HL, Mearin F, Gasbarrini A, Tack J. New concepts on intestinal microbiota and the role of the non-absorbable antibiotics with special reference to rifaximin in digestive diseases. Dig Liver Dis. 2018 Aug;50(8):741-749. doi: 10.1016/j.dld.2018.04.020.
- Khoruts A. Targeting the microbiome: from probiotics to fecal microbiota transplantation. Genome Medicine. 2018;10(1):80. doi:10.1186/s13073-018-0592-8
- Thursby E, Juge N. Introduction to the human gut microbiota. Biochemical Journal. 2017;474(11):1823-1836. doi:10.1042/BCJ20160510
- Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut Microbiota and Immune System Interactions. Microorganisms. 2020;8(10):1587. doi:10.3390/microorganisms8101587
- Pickard JM, Zeng MY, Caruso R, Núñez G. Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease. Immunological Reviews. 2017;279(1):70-89. doi:10.1111/imr.12567
- Hong SW, O E, Lee JY, et al. Food antigens drive spontaneous IgE elevation in the absence of commensal microbiota. Science Advances. 2019;5(5):eaaw1507. doi:10.1126/sciadv.aaw1507
- Gao C, Major A, Rendon D, et al. Histamine H2 Receptor-Mediated Suppression of Intestinal Inflammation by Probiotic Lactobacillus reuteri. mBio. 2015;6(6):10. 1128/mbio. 01358-15. doi:10.1128/mbio.01358-15
- Caetano-Silva ME, Rund L, Hutchinson NT, Woods JA, Steelman AJ, Johnson RW. Inhibition of inflammatory microglia by dietary fiber and short-chain fatty acids. Sci Rep. 2023;13(1):2819. doi:10.1038/s41598-022-27086-x
- Dicks LMT. Gut Bacteria and Neurotransmitters. Microorganisms. 2022;10(9):1838. doi:10.3390/microorganisms10091838
- Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. doi:10.3389/fendo.2020.00025
- Farzi A, Fröhlich EE, Holzer P. Gut Microbiota and the Neuroendocrine System. Neurotherapeutics. 2018;15(1):5-22. doi:10.1007/s13311-017-0600-5
- Portincasa P, Bonfrate L, Vacca M, et al. Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis. International Journal of Molecular Sciences. 2022;23(3):1105. doi:10.3390/ijms23031105
- Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science. 2018;359(6380):1151-1156. doi:10.1126/science.aao5774
- De la Cuesta-Zuluaga J, Mueller NT, Álvarez-Quintero R, et al. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors. Nutrients. 2019;11(1):51. doi:10.3390/nu11010051
- Tsigalou C, Paraschaki A, Karvelas A, et al. Gut microbiome and Mediterranean diet in the context of obesity. Current knowledge, perspectives and potential therapeutic targets. Metabolism Open. 2021;9:100081. doi:10.1016/j.metop.2021.100081
- Arhire LI, Padureanu SS, Gherasim A, Nita O, Oprescu AC, Gavril RS, Mihalache L. Is there a need for one-month medical follow-up after laparoscopic sleeve gastrectomy? Obes Surg. 2018; 28 (1): S107.
- Han H, Yi B, Zhong R, et al. From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Microbiome. 2021;9:162. doi:10.1186/s40168-021-01093-y
- Mihalache L, Gherasim A, Ni ă O, Ungureanu MC, Pădureanu SS, Gavril RS, Arhire LI. Effects of ghrelin in energy balance and body weight homeostasis. Hormones. 2016; 15(2): 186-196.
- Gavril OI, Arhire LI, Gavril RS, et al. Correlations between PNPLA3 Gene Polymorphisms and NAFLD in Type 2 Diabetic Patients. Medicina. 2021; 57(11): 1249.
- Gupta A, Osadchiy V, Mayer EA. Brain-gut-microbiome interactions in obesity and food addiction. Nat Rev Gastroenterol Hepatol. 2020 Nov;17(11):655-672. doi: 10.1038/s41575-020-0341-5
- Ma J, Piao X, Mahfuz S, Long S, Wang J. The interaction among gut microbes, the intestinal barrier and short chain fatty acids. Animal Nutrition. 2022;9:159-174. doi:10.1016/j.aninu.2021.09.012
- Willemsen LEM, Koetsier MA, van Deventer SJH, van Tol EAF. Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E1 and E2 production by intestinal myofibroblasts. Gut. 2003;52(10):1442-1447. Accessed July 11, 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1773837/
- Camilleri M. The Leaky Gut: Mechanisms, Measurement and Clinical Implications in Humans. Gut. 2019;68(8):1516-1526. doi:10.1136/gutjnl-2019-318427
- Stewart AS, Pratt-Phillips S, Gonzalez LM. Alterations in Intestinal Permeability: The Role of the “Leaky Gut” in Health and Disease. Journal of Equine Veterinary Science. 2017;52:10-22. doi:10.1016/j.jevs.2017.02.009
- Camilleri M, Vella A. What to do about the leaky gut. Gut. 2022;71(2):424-435. doi:10.1136/gutjnl-2021-325428
- Camilleri M. What is the leaky gut? Clinical considerations in humans. Current Opinion in Clinical Nutrition & Metabolic Care. 2021;24(5):473. doi:10.1097/MCO.0000000000000778
- Leaky brain in neurological and psychiatric disorders: Drivers and consequences - Gerwyn Morris, Brisa S Fernandes, Basant K Puri, Adam J Walker, Andre F Carvalho, Michael Berk, 2018. Accessed July 12, 2023. https://journals.sagepub.com/doi/full/10.1177/0004867418796955
- Wu H, Wang J, Teng T, et al. Biomarkers of intestinal permeability and blood-brain barrier permeability in adolescents with major depressive disorder. Journal of Affective Disorders. 2023;323:659-666. doi:10.1016/j.jad.2022.11.058
- Luczynski P, McVey Neufeld KA, Oriach CS, Clarke G, Dinan TG, Cryan JF. Growing up in a bubble: using germ-free animals to assess the influence of the gut microbiota on brain and behavior. International Journal of Neuropsychopharmacology. 2016 Aug 1;19(8):pyw020.
- Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterology& Motility. 2012;24(5):405-413. doi:10.1111/j.1365-2982.2012. 01906.x
- Kim HS. Do an Altered Gut Microbiota and an Associated Leaky Gut Affect COVID-19 Severity? mBio. 2021;12(1):10.1128/mbio.03022-20. doi:10.1128/mbio.03022-20
- Zhang Y, Geng X, Tan Y, et al. New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Biomed Pharmacother. 2020;127:110195. doi:10.1016/j.biopha.2020.110195
- Karim A, Muhammad T, Ustrana S, Qaisar R. Intestinal permeability marker zonulin as a predictor of sarcopenia in chronic obstructive pulmonary disease. Respiratory Medicine. 2021;189:106662. doi:10.1016/j.rmed.2021.106662
- Li N, Dai Z, Wang Z, et al. Gut microbiota dysbiosis contributes to the development of chronic obstructive pulmonary disease. Respir Res. 2021;22:274. doi:10.1186/s12931-021-01872-z
- Paray BA, Albeshr MF, Jan AT, Rather IA. Leaky Gut and Autoimmunity: An Intricate Balance in Individuals Health and the Diseased State. Int J Mol Sci. 2020;21(24):9770. doi:10.3390/ijms21249770
- Berer K, Gerdes LA, Cekanaviciute E, et al. Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice. Proceedings of the National Academy of Sciences. 2017;114(40):10719-10724. doi:10.1073/pnas.1711233114
- Damci T, Nuhoglu I, Devranoglu G, Osar Z, Demir M, Ilkova H. Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in Type 1 diabetic patients. European journal of clinical investigation. 2003 May;33(5):397-401.
- Watts T, Berti I, Sapone A, et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A. 2005;102(8):2916-2921. doi:10.1073/pnas.0500178102
- Yeoh N, Burton JP, Suppiah P, Reid G, Stebbings S. The Role of the Microbiome in Rheumatic Diseases. CurrRheumatol Rep. 2013;15(3):314. doi:10.1007/s11926 -012-0314-y
- Audo R, Sanchez P, Rivière B, et al. Rheumatoid arthritis is associated with increased gut permeability and bacterial translocation that are reversed by inflammation control. Rheumatology. 2023;62(3):1264-1271. doi:10.1093/rheumatology/keac454
- Zhong D, Wu C, Zeng X, Wang Q. The role of gut microbiota in the pathogenesis of rheumatic diseases. Clin Rheumatol. 2018;37(1):25-34. doi:10.1007/s10067-017-3821-4
- ZununiVahed S, Barzegari A, Zuluaga M, Letourneur D, Pavon-Djavid G. Myocardial infarction and gut microbiota: An incidental connection. Pharmacological Research. 2018;129:308-317. doi:10.1016/j.phrs.2017.11.008
- Novakovic M, Rout A, Kingsley T, et al. Role of gut microbiota in cardiovascular diseases. World J Cardiol. 2020;12(4):110-122. doi:10.4330/wjc.v12.i4.110
- Gavril RS, Mastaleru A, Mitu O, et al. Cardiovascular Risk Assesment in Nonalcoholic Fatty Liver Disease. Filodiritto Editore Proceedings. 2018: 38-41.
- Liu Y, Dai M. Trimethylamine N-Oxide Generated by the Gut Microbiota Is Associated with Vascular Inflammation: New Insights into Atherosclerosis. Mediators Inflamm. 2020;2020:4634172. doi:10.1155/2020/4634172
- Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS. 2020;128(5):353-366. doi:10.1111/apm.13038
- Tacconi E, Palma G, De Biase D, et al. Microbiota Effect on Trimethylamine N-Oxide Production: From Cancer to Fitness—A Practical Preventing Recommendation and Therapies. Nutrients. 2023;15(3):563. doi:10.3390/nu15030563
- He Z, Chen ZY. The origin of trimethylamine-N-oxide (TMAO) and its role in development of atherosclerosis. Journal of Food Bioactives. 2018;2:28-36. doi:10.31665/JFB.2018.2138
- Lau WL, Vaziri ND. The Leaky Gut and Altered Microbiome in Chronic Kidney Disease. Journal of Renal Nutrition. 2017;27(6):458-461. doi:10.1053/j.jrn.2017.02.010
- Lau WL, Savoj J, Nakata MB, Vaziri ND. Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. Clin Sci (Lond). 2018;132(5):509-522. doi:10.1042/CS20171107
- Rydzewska-Rosołowska A, Sroka N, Kakareko K, Rosołowski M, Zbroch E, Hryszko T. The Links between Microbiome and Uremic Toxins in Acute Kidney Injury: Beyond Gut Feeling—A Systematic Review. Toxins. 2020;12(12):788. doi:10.3390/toxins12120788
- Stengel A, Gourcerol G, Taché Y. Neurogastroenterology–Focus on the Gut-Brain Axis. Frontiers in Psychiatry. 2021 Mar 4;12:653910.
- Durgan DJ, Lee J, McCullough LD, Bryan RM Jr. Examining the Role of the Microbiota-Gut-Brain Axis in Stroke. Stroke. 2019 Aug;50(8):2270-2277. doi: 10.1161/STROKEAHA.119.025140. Epub 2019 Jul 5. PMID: 31272315; PMCID: PMC6646086.
- Sinagra E, Pellegatta G, Guarnotta V, Maida M, Rossi F, Conoscenti G, Pallio S, Alloro R, Raimondo D, Pace F, Anderloni A. Microbiota gut–brain axis in ischemic stroke: a narrative review with a focus about the relationship with inflammatory bowel disease. Life. 2021 Jul 19;11(7):715.
- Benakis C, Liesz A. The gut-brain axis in ischemic stroke: its relevance in pathology and as a therapeutic target. Neurol Res Pract. 2022;4(1):57. doi:10.1186/s42466-022-00222-8
- Zhang M na, Shi Y dan, Jiang H yin. The risk of dementia in patients with inflammatory bowel disease: a systematic review and meta-analysis. Int J Colorectal Dis. 2022;37(4):769-775. doi:10.1007/s00384-022-04131-9
- A. Kohler C, Maes M, Slyepchenko A, et al. The Gut-Brain Axis, Including the Microbiome, Leaky Gut and Bacterial Translocation: Mechanisms and Pathophysiological Role in Alzheimer's Disease. Current Pharmaceutical Design. 2016;22(40):6152-6166.
- Cells | Free Full-Text | Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins. Accessed July 12, 2023. https://www.mdpi.com/2073-4409/9/4/853
- Yang D, Zhao D, Ali Shah SZ, et al. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease. Frontiers in Neurology. 2019;10. Accessed July 12, 2023. https://www.frontiersin.org/articles/10.3389/fneur.2019.01155
- Dong S, Sun M, He C, Cheng H. Brain-gut-microbiota axis in Parkinson's disease: A historical review and future perspective. Brain Research Bulletin. 2022;183:84-93. doi:10.1016/j.brainresbull.2022.02.015
- Caiaffo V, Oliveira BD, de Sá FB, Evêncio Neto J. Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine. Pharmacology research & perspectives. 2016 Jun;4(3):e00231.
- Gałecki P, Mossakowska-Wójcik J, Talarowska M. The anti-inflammatory mechanism of antidepressants – SSRIs, SNRIs. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2018;80:291-294. doi:10.1016/j.pnpbp.2017.03.016
- Dinan TG, Stanton C, Cryan JF. Psychobiotics: A Novel Class of Psychotropic. Biological Psychiatry. 2013;74(10):720-726. doi:10.1016/j.biopsych.2013.05.001
- Cheng LH, Liu YW, Wu CC, Wang S, Tsai YC. Psychobiotics in mental health, neurodegenerative and neurodevelopmental disorders. Journal of Food and Drug Analysis. 2019;27(3):632-648. doi:10.1016/j.jfda.2019.01.002
- Evrensel A, Ünsalver BÖ, Ceylan ME. Psychobiotics. In: Kim YK, ed. Frontiers in Psychiatry: Artificial Intelligence, Precision Medicine, and Other Paradigm Shifts. Advances in Experimental Medicine and Biology. Springer; 2019:565-581. doi:10.1007/978-981-32-9721-0_28
- Bauer KC, Huus KE, Finlay BB. Microbes and the mind: emerging hallmarks of the gut microbiota–brain axis. Cellular Microbiology. 2016;18(5):632-644. doi:10.1111/cmi.12585
- Vuong HE, Hsiao EY. Emerging Roles for the Gut Microbiome in Autism Spectrum Disorder. Biological Psychiatry. 2017;81(5):411-423. doi:10.1016/j.biopsych.2016.08.024
- The microbiome and gut homeostasis | Science. Accessed July 12, 2023. https://www.science.org/doi/full/10.1126/science.abp9960
- QIN, Da, et al. Contribution of Lactobacilli on Intestinal Mucosal Barrier and Diseases: Perspectives and Challenges of Lactobacillus casei. Life, 2022, 12.11: 1910.
- RANUH, Reza, et al. Effect of the probiotic Lactobacillus plantarum IS-10506 on BDNF and 5HT stimulation: Role of intestinal microbiota on the gut-brain axis. Iranian Journal of Microbiology, 2019, 11.2: 145.
- Martoni CJ, Srivastava S, Leyer GJ. Lactobacillus acidophilus DDS-1 and Bifidobacterium lactis UABla-12 improve abdominal pain severity and symptomology in irritable bowel syndrome: randomized controlled trial. Nutrients. 2020 Jan 30;12(2):363.
- Tette FM, Kwofie SK, Wilson MD. Therapeutic anti-depressant potential of microbial GABA produced by Lactobacillus rhamnosus strains for GABAergic signaling restoration and inhibition of addiction-induced HPA axis hyperactivity. Current Issues in Molecular Biology. 2022 Mar 22;44(4):1434-51.
- Sushma G, Vaidya B, Sharma S, et al. Bifidobacterium breve Bif11 supplementation improves depression-related neurobehavioural and neuroinflammatory changes in the mouse. Neuropharmacology. 2023;229:109480. doi:10.1016/j.neuropharm.2023.109480
- Fattorusso A, Di Genova L, Dell'Isola GB, Mencaroni E, Esposito S. Autism spectrum disorders and the gut microbiota. Nutrients. 2019 Feb 28;11(3):521.
- Abdel-Wahab BA, F. Abd El-Kareem H, Alzamami A, A. Fahmy C, H. Elesawy B, Mostafa Mahmoud M, Ghareeb A, El Askary A, H. Abo Nahas H, GM Attallah N, Altwaijry N. Novel exopolysaccharide from marine Bacillus subtilis with broad potential biological activities: Insights into antioxidant, anti-Inflammatory, cytotoxicity, and anti-Alzheimer activity. Metabolites. 2022 Jul 31;12(8):715.
- Siesto G, Pietrafesa R, Infantino V, Thanh C, Pappalardo I, Romano P, Capece A. In vitro study of probiotic, antioxidant and anti-inflammatory activities among indigenous Saccharomyces cerevisiae strains. Foods. 2022 May 5;11(9):1342.
- Yaghoubfar R, Behrouzi A, Ashrafian F, Shahryari A, Moradi HR, Choopani S, Hadifar S, Vaziri F, Nojoumi SA, Fateh A, Khatami S. Modulation of serotonin signaling/metabolism by Akkermansiamuciniphila and its extracellular vesicles through the gut-brain axis in mice. Scientific reports. 2020 Dec 17;10(1):22119.
- Liu M, Zhang X, Hao Y, Ding J, Shen J, Xue Z, Qi W, Li Z, Song Y, Zhang T, Wang N. Protective effects of a novel probiotic strain, Lactococcus lactis ML2018, in colitis: in vivo and in vitro evidence. Food & function. 2019;10(2):1132-45.
- Hiergeist A, Gessner J, Gessner A. Current limitations for the assessment of the role of the gut microbiome for attention deficit hyperactivity disorder (ADHD). Frontiers in Psychiatry. 2020 Jun 26;11:623.
- SUN, Jing, et al. Effect of Clostridium butyricum against microglia-mediated neuroinflammation in Alzheimer's disease via regulating gut microbiota and metabolites butyrate. Molecular nutrition & food research, 2020, 64.2: 1900636.
- Chen L, Reynolds C, David R, Peace Brewer A. Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results. Dig Dis Sci. 2020;65(4):1111-1124. doi:10.1007/s10620-019-05828-8.